Walker's Research Business Information
A publisher of Business Information since 1983  
  
 
Search Business Search Executive   Advanced Search
 
Sign In  |  Hints

Profile of Robert Nicora
 

Robert Nicora

 
Dir., Pres., CEO - Synthetic Blood International Inc.
 
Robert Nicora Email :
Please login
 
Company Name : Synthetic Blood International Inc.
 
Company Website : www.sybd.com
 
Company Address : 3189 Airway Ave.
Bldg. C, Costa Mesa, CA,
United States,
 
Robert Nicora Profile :
Dir., Pres., CEO - Synthetic Blood International Inc.
 
Robert Nicora Biography :

Robert W. Nicora became the President, Chief Executive Officer and Director on March 1, 1998. Mr. Nicora has BS in chemistry, five years of graduate study in biochemistry and medical sciences, and over 30 years of experience in various laboratory, management and regulatory positions with pharmaceutical and medical device companies. While at McGaw Laboratories, he was responsible for the development and FDA approval of hetastarch, a synthetic blood expander, now marketed by DuPont Pharma. He led the team that evaluated a joint partnership with Green Cross to develop their perfluorocarbon blood substitute, Fluosol. From 1994 through March 1998, he was director of scientific and regulatory services with Quintiles, the world’s largest global contact pharmaceutical company. He has provided preclinical and clinical drug and device consulting services to a number of startup biomedical companies.

 
Robert Nicora Colleagues :
Name Title Email

Richard Kiral

VP - Product Development, Dir. Please login

Douglas Kornbrust

Consultant - Preclinical Toxicology, Pharmacolog Please login

Anthony Fox

Consulting Clinical Pharmacologist Please login

Jonathan Spees

Dir. Please login

Chris Stern

CEO Please login


            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory   
 

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.